Publication | Closed Access

Phase Ib study of the MEK inhibitor cobimetinib (GDC-0973) in combination with the PI3K inhibitor pictilisib (GDC-0941) in patients with advanced solid tumors

Phase Ib StudyMek Inhibitor CobimetinibPi3k Inhibitor PictilisibMedicinePharmacologyAnti-cancer AgentCancer TreatmentOncologyRadiation Oncology